Selected research
Industry Growth & Trends
Global Livestock Anti-infectives Industry Growth and Trends Forecast to 2032
Market perspective
The global Livestock Anti-infectives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Livestock Anti-infectives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Livestock Anti-infectives is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Livestock Anti-infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Livestock Anti-infectives include Bimeda Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Chanelle, Elanco, Vetoquinol, Virbac, Bayer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Livestock Anti-infectives market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Livestock Anti-infectives market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Livestock Anti-infectives market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Livestock Anti-infectives.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Livestock Anti-infectives market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Livestock Anti-infectives Market by Company
Bimeda Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Chanelle
Elanco
Vetoquinol
Virbac
Bayer
Merck
Zoetis
Livestock Anti-infectives Segment by Type
External Use
Internal Use
Livestock Anti-infectives Segment by Application
Other
Sheep
Cattle
Pigs
Livestock Anti-infectives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Livestock Anti-infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Livestock Anti-infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Livestock Anti-infectives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Livestock Anti-infectives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Livestock Anti-infectives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- External Use
- Internal Use
Applications
- Other
- Sheep
- Cattle
- Pigs
Companies covered
- Bimeda Animal Health
- Boehringer Ingelheim
- Ceva Sante Animale
- Chanelle
- Elanco
- Vetoquinol
- Virbac
- Bayer
- Merck
- Zoetis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Livestock Anti-infectives Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Livestock Anti-infectives Sales Estimates and Forecasts (2021-2032)
- 1.3 Livestock Anti-infectives Market by Type
- 1.3.1 External Use
- 1.3.2 Internal Use
- 1.4 Global Livestock Anti-infectives Market Size by Type
- 1.4.1 Global Livestock Anti-infectives Market Size Overview by Type (2021-2032)
- 1.4.2 Global Livestock Anti-infectives Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Livestock Anti-infectives Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Livestock Anti-infectives Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Livestock Anti-infectives Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Livestock Anti-infectives Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Livestock Anti-infectives Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Livestock Anti-infectives Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Livestock Anti-infectives Industry Trends
- 2.2 Livestock Anti-infectives Industry Drivers
- 2.3 Livestock Anti-infectives Industry Opportunities and Challenges
- 2.4 Livestock Anti-infectives Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Livestock Anti-infectives Revenue (2021-2026)
- 3.2 Global Top Players by Livestock Anti-infectives Sales (2021-2026)
- 3.3 Global Top Players by Livestock Anti-infectives Price (2021-2026)
- 3.4 Global Livestock Anti-infectives Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Livestock Anti-infectives Major Company Production Sites & Headquarters
- 3.6 Global Livestock Anti-infectives Company, Product Type & Application
- 3.7 Global Livestock Anti-infectives Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Livestock Anti-infectives Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Livestock Anti-infectives Players Market Share by Revenue in 2025
- 3.8.3 2025 Livestock Anti-infectives Tier 1, Tier 2, and Tier 3
4 Livestock Anti-infectives Regional Status and Outlook
- 4.1 Global Livestock Anti-infectives Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Livestock Anti-infectives Historic Market Size by Region
- 4.2.1 Global Livestock Anti-infectives Sales in Volume by Region (2021-2026)
- 4.2.2 Global Livestock Anti-infectives Sales in Value by Region (2021-2026)
- 4.2.3 Global Livestock Anti-infectives Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Livestock Anti-infectives Forecasted Market Size by Region
- 4.3.1 Global Livestock Anti-infectives Sales in Volume by Region (2027-2032)
- 4.3.2 Global Livestock Anti-infectives Sales in Value by Region (2027-2032)
- 4.3.3 Global Livestock Anti-infectives Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Livestock Anti-infectives by Application
- 5.1 Livestock Anti-infectives Market by Application
- 5.1.1 Other
- 5.1.2 Sheep
- 5.1.3 Cattle
- 5.1.4 Pigs
- 5.2 Global Livestock Anti-infectives Market Size by Application
- 5.2.1 Global Livestock Anti-infectives Market Size Overview by Application (2021-2032)
- 5.2.2 Global Livestock Anti-infectives Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Livestock Anti-infectives Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Livestock Anti-infectives Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Livestock Anti-infectives Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Livestock Anti-infectives Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Livestock Anti-infectives Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Livestock Anti-infectives Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Bimeda Animal Health
- 6.1.1 Bimeda Animal Health Company Information
- 6.1.2 Bimeda Animal Health Business Overview
- 6.1.3 Bimeda Animal Health Livestock Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Bimeda Animal Health Livestock Anti-infectives Product Portfolio
- 6.1.5 Bimeda Animal Health Recent Developments
- 6.2 Boehringer Ingelheim
- 6.2.1 Boehringer Ingelheim Company Information
- 6.2.2 Boehringer Ingelheim Business Overview
- 6.2.3 Boehringer Ingelheim Livestock Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Boehringer Ingelheim Livestock Anti-infectives Product Portfolio
- 6.2.5 Boehringer Ingelheim Recent Developments
- 6.3 Ceva Sante Animale
- 6.3.1 Ceva Sante Animale Company Information
- 6.3.2 Ceva Sante Animale Business Overview
- 6.3.3 Ceva Sante Animale Livestock Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Ceva Sante Animale Livestock Anti-infectives Product Portfolio
- 6.3.5 Ceva Sante Animale Recent Developments
- 6.4 Chanelle
- 6.4.1 Chanelle Company Information
- 6.4.2 Chanelle Business Overview
- 6.4.3 Chanelle Livestock Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Chanelle Livestock Anti-infectives Product Portfolio
- 6.4.5 Chanelle Recent Developments
- 6.5 Elanco
- 6.5.1 Elanco Company Information
- 6.5.2 Elanco Business Overview
- 6.5.3 Elanco Livestock Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Elanco Livestock Anti-infectives Product Portfolio
- 6.5.5 Elanco Recent Developments
- 6.6 Vetoquinol
- 6.6.1 Vetoquinol Company Information
- 6.6.2 Vetoquinol Business Overview
- 6.6.3 Vetoquinol Livestock Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Vetoquinol Livestock Anti-infectives Product Portfolio
- 6.6.5 Vetoquinol Recent Developments
- 6.7 Virbac
- 6.7.1 Virbac Company Information
- 6.7.2 Virbac Business Overview
- 6.7.3 Virbac Livestock Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Virbac Livestock Anti-infectives Product Portfolio
- 6.7.5 Virbac Recent Developments
- 6.8 Bayer
- 6.8.1 Bayer Company Information
- 6.8.2 Bayer Business Overview
- 6.8.3 Bayer Livestock Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Bayer Livestock Anti-infectives Product Portfolio
- 6.8.5 Bayer Recent Developments
- 6.9 Merck
- 6.9.1 Merck Company Information
- 6.9.2 Merck Business Overview
- 6.9.3 Merck Livestock Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Merck Livestock Anti-infectives Product Portfolio
- 6.9.5 Merck Recent Developments
- 6.10 Zoetis
- 6.10.1 Zoetis Company Information
- 6.10.2 Zoetis Business Overview
- 6.10.3 Zoetis Livestock Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Zoetis Livestock Anti-infectives Product Portfolio
- 6.10.5 Zoetis Recent Developments
7 North America by Country
- 7.1 North America Livestock Anti-infectives Sales by Country
- 7.1.1 North America Livestock Anti-infectives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Livestock Anti-infectives Sales by Country (2021-2026)
- 7.1.3 North America Livestock Anti-infectives Sales Forecast by Country (2027-2032)
- 7.2 North America Livestock Anti-infectives Market Size by Country
- 7.2.1 North America Livestock Anti-infectives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Livestock Anti-infectives Market Size by Country (2021-2026)
- 7.2.3 North America Livestock Anti-infectives Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Livestock Anti-infectives Sales by Country
- 8.1.1 Europe Livestock Anti-infectives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Livestock Anti-infectives Sales by Country (2021-2026)
- 8.1.3 Europe Livestock Anti-infectives Sales Forecast by Country (2027-2032)
- 8.2 Europe Livestock Anti-infectives Market Size by Country
- 8.2.1 Europe Livestock Anti-infectives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Livestock Anti-infectives Market Size by Country (2021-2026)
- 8.2.3 Europe Livestock Anti-infectives Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Livestock Anti-infectives Sales by Country
- 9.1.1 Asia-Pacific Livestock Anti-infectives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Livestock Anti-infectives Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Livestock Anti-infectives Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Livestock Anti-infectives Market Size by Country
- 9.2.1 Asia-Pacific Livestock Anti-infectives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Livestock Anti-infectives Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Livestock Anti-infectives Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Livestock Anti-infectives Sales by Country
- 10.1.1 South America Livestock Anti-infectives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Livestock Anti-infectives Sales by Country (2021-2026)
- 10.1.3 South America Livestock Anti-infectives Sales Forecast by Country (2027-2032)
- 10.2 South America Livestock Anti-infectives Market Size by Country
- 10.2.1 South America Livestock Anti-infectives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Livestock Anti-infectives Market Size by Country (2021-2026)
- 10.2.3 South America Livestock Anti-infectives Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Livestock Anti-infectives Sales by Country
- 11.1.1 Middle East and Africa Livestock Anti-infectives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Livestock Anti-infectives Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Livestock Anti-infectives Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Livestock Anti-infectives Market Size by Country
- 11.2.1 Middle East and Africa Livestock Anti-infectives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Livestock Anti-infectives Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Livestock Anti-infectives Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Livestock Anti-infectives Value Chain Analysis
- 12.1.1 Livestock Anti-infectives Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Livestock Anti-infectives Production Mode & Process
- 12.2 Livestock Anti-infectives Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Livestock Anti-infectives Distributors
- 12.2.3 Livestock Anti-infectives Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst